1. Home
  2. BCTX vs AWRE Comparison

BCTX vs AWRE Comparison

Compare BCTX & AWRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BriaCell Therapeutics Corp.

BCTX

BriaCell Therapeutics Corp.

HOLD

Current Price

$3.72

Market Cap

26.6M

Sector

Health Care

ML Signal

HOLD

Logo Aware Inc.

AWRE

Aware Inc.

HOLD

Current Price

$1.27

Market Cap

29.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCTX
AWRE
Founded
2014
1986
Country
Canada
United States
Employees
4
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
26.6M
29.2M
IPO Year
2025
1996

Fundamental Metrics

Financial Performance
Metric
BCTX
AWRE
Price
$3.72
$1.27
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$40.00
N/A
AVG Volume (30 Days)
162.5K
33.7K
Earning Date
06-15-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$380.95
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.61
$1.02
52 Week High
$14.68
$2.95

Technical Indicators

Market Signals
Indicator
BCTX
AWRE
Relative Strength Index (RSI) 59.34 45.20
Support Level $3.66 $1.31
Resistance Level $4.51 $1.42
Average True Range (ATR) 0.27 0.08
MACD 0.09 -0.01
Stochastic Oscillator 74.77 22.73

Price Performance

Historical Comparison
BCTX
AWRE

About BCTX BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

About AWRE Aware Inc.

Aware Inc provides biometric identity and authentication solutions. Its Awareness Platform transforms biometric data into actionable intelligence, allowing its clients to verify identities and authenticate access and transactions. The company's products span multiple biometric modalities, including fingerprint, face, iris, and voice. It offers: a broad range of biometrics software products and solutions, including platforms like AwareSDK, AwareABIS, AFIX Suite of Products, Awareness Platform, and WebEnroll; software components such as SDKs, APIs, and applications that customers use to develop their systems into more effective solutions; and several program management and software engineering services. Aware earns maximum revenue from the U.S., followed by the UK and the rest of the world.

Share on Social Networks: